You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. STTR Phase I:Refrigerant Ionic liquid Separation

    SBC: ICONIUM ENGINEERING COMPANY            Topic: CT

    The broader impact/commercial potential of this Small Business Technology Transfer (STTR) Phase I project will be to provide the refrigerant industry with the first commercial designs for separating complex, multi-component, azeotropic refrigerant mixtures for economical recycling. The American Innovation and Manufacturing Act authorizes the Environmental Protection Agency (EPA) to phase down prod ...

    STTR Phase I 2023 National Science Foundation
  2. STTR Phase I:Registration of Below-Canopy, Above-Canopy, and Satellite Sensor Streams for Forest Inventories

    SBC: GAIA AI, INC            Topic: ET

    The broader/commercial impact of this Small Business Technology Transfer (STTR) Phase I project is to increase the volume and improve the accuracy of data on the world’s forests. Presently, when collecting data on forests, surveyors must choose between slow, laborious methods, or quick but inaccurate ones. This project uses recent advances in sensors and machine learning to greatly improve data ...

    STTR Phase I 2023 National Science Foundation
  3. A 15 T Superconducting Magnet for 350 GHz, 1 MW Class Gyrotrons for Commercial Fusion Reactors

    SBC: BRIDGE 12 TECHNOLOGIES, INC.            Topic: C5630a

    C56-30a-273585Electron cyclotron resonance heating is a key fusion technology for: a) plasma heating; b) instability control, to stabilize instabilities such as those from Neoclassical Tearing Modes; and c) electron cyclotron assisted startup. Gyrotrons are a proven vacuum tube technology that can generate sufficient power during continuous operation to satisfy these requirements. In this Phase I ...

    STTR Phase I 2023 Department of Energy
  4. GaN Quad-Active-Bridge Converter for Hybrid PV-Battery Systems

    SBC: EPOWER TECHNOLOGY LLC            Topic: C5615a

    A quad-active-bridge (QAB) multiport converter will be developed based on an innovative circuit topology, a high-frequency planar magnetic transformer, and the latest generation of wide bandgap (WBG) transistors. The WBG-based QAB converter will provide a high-efficiency and ultra-compact interface capable of connecting with an array of photovoltaic (PV) panels, battery packs, electric vehicles (E ...

    STTR Phase I 2023 Department of Energy
  5. C55-04a: Software for Automatic Control, Calibration and Validation of Quantum Processors

    SBC: ATLANTIC QUANTUM CORP            Topic: C5504a

    Quantum computers has the potential to revolutionize computing, solving problems in chemistry, material science and optimization that are beyond the reach of today's most powerful supercomputers. However, we are still in the early phase of the technology development, and today’s quantum hardware systems suffer from drift and imperfections and require frequent calibrations to operate properly. Th ...

    STTR Phase I 2023 Department of Energy
  6. Developing Active Stimulation and Monitoring Technologies to Optimize Pain and Nociception Management During Regional Anesthesia, General Anesthesia, and Post-Operative Care

    SBC: PASCALL Systems, Incorporated            Topic: 106

    Project Summary Surgery and acute post-operative pain are major contributors to persistent pain, chronic pain, and opioid dependence. Currently, there are no products on the market in the United States that can be used to monitor surgical nociception. Existing products use indicators that are susceptible to intraoperative influences such as blood loss, anesthetic drugs and antihypertensives. This ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  7. Controlled Gradient Release of Biologics: Enhanced Nerve Conduit for Long‐Gap Injury Repair

    SBC: Pioneer Neurotech Inc.            Topic: 106

    Project Summary / Abstract Nerve injuries arising from trauma, disease, or as a surgical necessity, lead most often to permanent loss of some or all functions mediated by the injured nerves. 50,000 peripheral nerve procedures are performed every year in the US, and 300,000 across Europe. After complete transection of a nerve, the optimal clinical procedure for nerve repair remains the surgical end ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  8. Developing a virtual reality guided acupuncture imagery treatment for Chronic low back pain

    SBC: MASSACHUSETTS NEURO TECHNOLOGY, INC.            Topic: NCCIH

    Project Summary Low back pain (LBP) is one of the most common reasons for physician visits in the USA. A substantial number of chronic LBP (cLBP) patients do not adequately respond to current treatment options. Thus, the development of new treatments for cLBP is urgently needed. The use of imagery to treat illness, including chronic pain, is one of the oldest medical practices. Although still unde ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Development of an Orally Available Therapeutic for Neutralizing C. difficile Toxin B

    SBC: NECTAGEN INC            Topic: NIAID

    Infection with the bacterium C. difficile is the most common and increasingly prevalent cause of diarrhea. In the United States, cases of C. difficile infection (CDI) are estimated to number 500,000 annually and to result in an estimated 15,000 to 30,000 deaths. The cost of these cases is thought to exceed $4.8 billion annually. CDI continues to cause discomfort, serious illness and sometimes deat ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  10. Targeting glioblastoma with CM93, a novel EGFR inhibitor with exceptional brain penetration

    SBC: CRIMSON BIOPHARM INC            Topic: NCI

    PROJECT SUMMARY The epidermal growth factor receptor (EGFR) gene is mutated and/or amplified in majority of primary glioblastoma (GBM). While EGFR-mutant GBM cancer cells are dependent on EGFR signaling for survival, numerous small molecule EGFR tyrosine kinase inhibitors (TKIs) have failed to show efficacy in this disease. There are two main reasons for these failures: i) Many of these EGFR-TKIs ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government